Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer

Autorzy:
Magdalena Rodak, Institute of Nuclear Chemistry and Technology, Warsaw, Poland, uczestniczka projektu RadFarm,

Yana Dekempeneer, Department of Medical Imaging, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium

Maria Wojewódzka, Institute of Nuclear Chemistry and Technology, Warsaw, Poland

Vicky Caveliers Department of Medical Imaging, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium, Nuclear Medicine Department, UZ Brussel, Brussels, Belgium

Peter Covens, Department of Medical Imaging, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium

Brian W. Miller, Department of Medical Imaging, University of Arizona, Tucson, Arizona, USA

Matthijs B. Sevenois, Department of Medical Imaging, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium

Frank Bruchertseifer, European Commission, Joint Research Centre (JRC), Karlsruhe, Germany

Alfred Morgenstern, European Commission, Joint Research Centre (JRC), Karlsruhe, Germany

Tony Lahoutte, Department of Medical Imaging, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium, Nuclear Medicine Department, UZ Brussel, Brussels, Belgium

Matthias D’Huyvetter, Department of Medical Imaging, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium

Marek Pruszyński, Institute of Nuclear Chemistry and Technology, Warsaw, Poland, NOMATEN Centre of Excellence, National Centre for Nuclear Research, Otwock, Poland

Finansowanie:
This study was supported by grant funding from the National Science Centre, Poland (SONATA-BIS9 research project 2019/34/E/ST4/00080) and supported by bilateral cooperation between Research Foundation-Flanders (FWO) and Polish Academy of Sciences (PAS). T. Lahoutte is Senior Clinical Investigator and M. D’Huyvetter is postdoctoral fellow of the FWO. M. Rodak was funded by Operational Project Knowledge Education Development, co-financed by the European Social Fund (POWR.03.02.00-00- I009/17-00) - publikacja w ramach RadFarm

Rok wydania:
2022

Liczba tomów:
1

Liczba stron:
29